An artificial intelligence decision support system for the management of type 1 diabetes
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Type 1 diabetes (T1D) is characterized by pancreatic beta cell dysfunction and insulin depletion. Over 40% of people with T1D manage their glucose through multiple injections of long-acting basal and short-acting bolus insulin, so-called multiple daily injections (MDI)1,2. Errors in dosing can lead to life-threatening hypoglycaemia events (<70 mg dl−1) and hyperglycaemia (>180 mg dl−1), increasing the risk of retinopathy, neuropathy, and nephropathy. Machine learning (artificial intelligence) approaches are being harnessed to incorporate decision support into many medical specialties. Here, we report an algorithm that provides weekly insulin dosage recommendations to adults with T1D using MDI therapy. We employ a unique virtual platform3 to generate over 50,000 glucose observations to train a k-nearest neighbours4 decision support system (KNN-DSS) to identify causes of hyperglycaemia or hypoglycaemia and determine necessary insulin adjustments from a set of 12 potential recommendations. The KNN-DSS algorithm achieves an overall agreement with board-certified endocrinologists of 67.9% when validated on real-world human data, and delivers safe recommendations, per endocrinologist review. A comparison of inter-physician-recommended adjustments to insulin pump therapy indicates full agreement of 41.2% among endocrinologists, which is consistent with previous measures of inter-physician agreement (41–45%)5. In silico3,6 benchmarking using a platform accepted by the United States Food and Drug Administration for evaluation of artificial pancreas technologies indicates substantial improvement in glycaemic outcomes after 12 weeks of KNN-DSS use. Our data indicate that the KNN-DSS allows for early identification of dangerous insulin regimens and may be used to improve glycaemic outcomes and prevent life-threatening complications in people with T1D. An automated decision support system is reported that provides weekly insulin dosage recommendations to users with T1D and that, when analysing previously collected patient data, exhibits high agreement with recommendations from physicians.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nearest neighbor pattern classification
Cover, T., & Hart, P. (1967) · IEEE Transactions on Information Theory · doi:10.1109/tit.1967.1053964 · Cited by 16,936
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254 · cited 2×
“The mutual information between two random variables (for example, a feature f with a distribution F and a recommendation r with a distribution R) with a joint probability mass function (PFR) is defined according to equation (2).”
BackgroundMethodBeck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
The UVA/PADOVA Type 1 Diabetes Simulator: New Features
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813514502 · Cited by 791 · cited 2×
“We evaluated the ability of the KNN-DSS to improve glycae-mic outcomes using two virtual patient simulators 3,6 .”
BackgroundMethodThe Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-1990 · Cited by 712
Kirwan, M., Vandelanotte, C., Fenning, A., & Duncan, M. J. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2588 · Cited by 343
Charpentier, G., Benhamou, P.-Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1259 · Cited by 292
Wu, Y., Yao, X., Vespasiani, G., Nicolucci, A., Dong, Y., Kwong, J., Li, L., Sun, X., Tian, H., & Li, S. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.6522 · Cited by 283
Rapid evidence review of mobile applications for self-management of diabetes
Veazie, S., Winchell, K., Gilbert, J., Paynter, R., Ivlev, I., Eden, K. B., Nussbaum, K., Weiskopf, N., Guise, J.-M., & Helfand, M. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4410-1 · Cited by 170
Castle, J. R., El Youssef, J., Wilson, L. M., Reddy, R., Resalat, N., Branigan, D., Ramsey, K., Leitschuh, J., Rajhbeharrysingh, U., Senf, B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0228 · Cited by 152
Self-citation
Cited by
Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. K., The SPIRIT-AI and CONSORT-AI Working Group, SPIRIT-AI and CONSORT-AI Steering Group, Chan, A.-W., Darzi, A., Holmes, C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1034-x · Cited by 1,421
Cruz Rivera, S., Liu, X., Chan, A.-W., Denniston, A. K., Calvert, M. J., The SPIRIT-AI and CONSORT-AI Working Group, SPIRIT-AI and CONSORT-AI Steering Group, Darzi, A., Holmes, C., Yau, C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1037-7 · Cited by 933
Liu, X., Rivera, S. C., Moher, D., Calvert, M. J., & Denniston, A. K. (2020) · BMJ · doi:10.1136/bmj.m3164 · Cited by 702
Wearable chemical sensors for biomarker discovery in the omics era
Sempionatto, J. R., Lasalde-Ramírez, J. A., Mahato, K., Wang, J., & Gao, W. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00439-w · Cited by 613
Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. K., Ashrafian, H., Beam, A. L., Chan, A.-W., Collins, G. S., Deeks, A. D. J., et al. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30218-1 · Cited by 555
“24 However, in the most recent cases, published evidence has consisted of in-silico, early-phase validation.”
Metadata
- Authors
- Tyler, N. S., Mosquera-Lopez, C. M., Wilson, L. M., Dodier, R. H., Branigan, D. L., Gabo, V. B., Guillot, F. H., Hilts, W. W., El Youssef, J., Castle, J. R., & Jacobs, P. G.
- Venue
- Nature Metabolism
- Published
- 2020-06-01
- Volume
- 2
- Issue
- 7
- Pages
- 612-619
- ISSN
- 2522-5812 (ISSN-L)
- OpenAlex
- W3031602164
- Cited by
- 163
- References
- 13
- FWCI
- 13.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An artificial intelligence decision support system for the management of type 1 diabetes. https://app.cochat.ai/papers/10.1038/s42255-020-0212-y
- The paper
- Tyler, N. S., Mosquera-Lopez, C. M., Wilson, L. M., Dodier, R. H., Branigan, D. L., Gabo, V. B., Guillot, F. H., Hilts, W. W., El Youssef, J., Castle, J. R., & Jacobs, P. G. (2020). An artificial intelligence decision support system for the management of type 1 diabetes. Nature Metabolism. https://doi.org/10.1038/s42255-020-0212-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.